Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.468 EUR
−23.49 M EUR
0.00 EUR
9.84 M
About PHAXIAM THERAPEUTICS
Sector
CEO
Thibaut du Fayet
Headquarters
Lyon
Website
Founded
2004
ISIN
FR001400K4B1
FIGI
BBG004G3ZZS1
PHAXIAM Therapeutics SA operates as a biopharmaceutical company. It engages in the development of treatments for resistant bacterial infections. The firm develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to combat bacterial infections in humans, particularly those resistant to antibiotics. The company was founded in 2004 and is headquartered in Lyon, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PHXM is 1.790 EUR — it has decreased by −0.22% in the past 24 hours. Watch PHAXIAM THERAPEUTICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange PHAXIAM THERAPEUTICS stocks are traded under the ticker PHXM.
PHXM stock has risen by 11.60% compared to the previous week, the month change is a −3.24% fall, over the last year PHAXIAM THERAPEUTICS has showed a −58.26% decrease.
We've gathered analysts' opinions on PHAXIAM THERAPEUTICS future price: according to them, PHXM price has a max estimate of 5.30 EUR and a min estimate of 4.90 EUR. Watch PHXM chart and read a more detailed PHAXIAM THERAPEUTICS stock forecast: see what analysts think of PHAXIAM THERAPEUTICS and suggest that you do with its stocks.
PHXM reached its all-time high on Aug 4, 2015 with the price of 371.546 EUR, and its all-time low was 1.500 EUR and was reached on Sep 27, 2024. View more price dynamics on PHXM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PHXM stock is 1.47% volatile and has beta coefficient of 0.15. Track PHAXIAM THERAPEUTICS stock price on the chart and check out the list of the most volatile stocks — is PHAXIAM THERAPEUTICS there?
Today PHAXIAM THERAPEUTICS has the market capitalization of 17.92 M, it has decreased by −1.30% over the last week.
Yes, you can track PHAXIAM THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
PHAXIAM THERAPEUTICS is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
PHXM net income for the last half-year is −10.63 M EUR, while the previous report showed −11.29 M EUR of net income which accounts for 5.78% change. Track more PHAXIAM THERAPEUTICS financial stats to get the full picture.
No, PHXM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 68.00 employees. See our rating of the largest employees — is PHAXIAM THERAPEUTICS on this list?
Like other stocks, PHXM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHAXIAM THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHAXIAM THERAPEUTICS technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHAXIAM THERAPEUTICS stock shows the sell signal. See more of PHAXIAM THERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.